Gilead Sciences in Saudi Arabia recently announced that Gilead and Kite Oncology is expanding its business with the launch of operations in Brazil, Saudi Arabia and Singapore. Gilead has submitted regulatory applications for Kite’s CAR T-cell therapy products in all three countries. Advanced blood cancers represent an area of significant need across all three countries. In both Singapore and Saudi Arabia, lymphomas are the fifth most common cancer overall; more than 1,000 new cases of non-Hodgkin lymphoma (NHL) are diagnosed…